The 2014 BIO International Convention has partnered with the National Institutes of Health and the National Science Foundation to feature Small Business Innovation Research (SBIR) funded early-stage biotech companies in a newly-created Innovation Zone. The Small Business Innovation Research (SBIR) program provides U.S. federal funding to small businesses engaged in Research/R&D with the potential for commercialization. Companies are rigorously vetted through the NIH and NSF SBIR review process prior to receiving the funding. The majority of participating companies in the Innovation Zone have received SBIR Phase II grants, which provide up to $1 million dollars in funding to engage in R&D that has the potential for commercialization.
The Innovation Zone companies, focused on drug discovery, diagnostics and other platform technologies, will have dedicated exhibit space and participate in BIO’s One-on-One Partnering™ system. Visit the Innovation Zone in the BIO Exhibition to meet 50+ SBIR grantees supported by the National Institutes of Health and the National Science Foundation. Select companies featured in the Zone will tell their story in a special track of company presentations.
If you are interested in exhibiting in the Innovation Zone, please contact Fabien Rabanal at email@example.com.